Showing results (371-380 of 419) with videos related to
Sort By:
Pageof 42
Clinical Immunology (Orlando, Fla.)|August 17, 2017
The unmet need in rheumatology: Reports from the targeted therapies meeting 2017Kevin L Winthrop, Vibeke Strand, Désirée van der Heijde, et al.RMD Open|October 18, 2024
Efficacy and safety of CT-P47 versus reference tocilizumab: 32-week results of a randomised, active-controlled, double-blind, phase III study in patients with rheumatoid arthritis, including 8 weeks of switching data from reference tocilizumab to CT-P47Josef S Smolen, Jakub Trefler, Artur Racewicz, et al.Arthritis Research & Therapy|September 15, 2021
The citrullinated/native index of autoantibodies against hnRNP-DL predicts an individual "window of treatment success" in RA patientsBianka Marklein, Madeleine Jenning, Zoltán Konthur, et al.Annals of the Rheumatic Diseases|December 2, 2017
Monocyte alterations in rheumatoid arthritis are dominated by preterm release from bone marrow and prominent triggering in the jointBiljana Smiljanovic, Anna Radzikowska, Ewa Kuca-Warnawin, et al.Annals of the Rheumatic Diseases|February 19, 2017
A randomised phase IIb study of mavrilimumab, a novel GM-CSF receptor alpha monoclonal antibody, in the treatment of rheumatoid arthritisGerd R Burmester, Iain B McInnes, Joel Kremer, et al.Lancet (London, England)|August 25, 2004
Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trialMichael E Farkouh, Howard Kirshner, Robert A Harrington, et al.Annals of the Rheumatic Diseases|June 7, 2020
EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2Robert Bm Landewé, Pedro M Machado, Féline Kroon, et al.Journal of Clinical Medicine|July 14, 2023
Intestinal Microbiota Reduction Followed by Fasting Discloses Microbial Triggering of Inflammation in Rheumatoid ArthritisThomas Häupl, Till Sörensen, Biljana Smiljanovic, et al.Clinical and Experimental Rheumatology|March 3, 2022
Blood biomarkers recommended for diagnosing and monitoring IgG4-related disease. Considerations from the ERN ReCONNET and collaborating partnersLuca Iaccarino, Rosaria Talarico, Emanuele Bozzalla-Cassione, et al.American Journal of Respiratory and Critical Care Medicine|September 3, 2014
Vascular receptor autoantibodies in pulmonary arterial hypertension associated with systemic sclerosisMike O Becker, Angela Kill, Marissa Kutsche, et al.Pageof 42